Home/Filings/4/0001213900-19-005488
4//SEC Filing

Bell John K 4

Accession 0001213900-19-005488

CIK 0001498382other

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 4:27 PM ET

Size

4.8 KB

Accession

0001213900-19-005488

Insider Transaction Report

Form 4
Period: 2019-03-29
Bell John K
Director
Transactions
  • Other

    Common Stock

    2019-03-29$0.49/sh+282$13896,711 total(indirect: Held by Onbelay Capital Inc.)
Footnotes (1)
  • [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.

Documents

1 file

Issuer

DelMar Pharmaceuticals, Inc.

CIK 0001498382

Entity typeother

Related Parties

1
  • filerCIK 0001569585

Filing Metadata

Form type
4
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:27 PM ET
Size
4.8 KB